Checkmate Pharmaceuticals Stock

checkmatepharma.comHealthcareFounded: 2015Funding to Date: $82MM

Checkmate Pharmaceuticals is a clinical stage biopharmaceutical company focused on activation of innate immunity to treat cancer.

Register for Details

For more details on financing and valuation for Checkmate Pharmaceuticals, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Checkmate Pharmaceuticals.

Register Today

Team

Management Team

Art Krieg MD
Founder, Chief Scientific Officer & Board Member
David Mauro Ph.D
Chief Medical Officer
Karen Brennan
Chief Operations Officer
Kleem Chaudhary Ph.D
Chief Business Officer
James Wooldridge
Chief Medical Officer
Chuck Abdalian
Chief Financial Officer
Barry Labinger
Chief Executive Officer, Board Member & President

Board Members

Art Krieg MD
Keith Flaherty MD
Alan Fuhrman
Michael Powell Ph.D
Sofinnova Investments
Ben Auspitz
F-Prime Capital Partners
Corey Goodman Ph.D
venBio

Other companies like Checkmate Pharmaceuticals in the Healthcare sector

Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$4.8B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM

News

CAMBRIDGE, Mass., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI), a clinical stage biotechnology company focused on...
Checkmate Pharmaceuticals, a Cambridge, MA-based clinical stage biotechnology company with a novel approach to cancer immunotherapy, completed an $85m Series C financing